Marriner Kirsten 4

What Happened

• Kirsten Marriner, Executive Vice President & Chief Administrative Officer of Clorox (CLX), received a grant of 26,324 restricted stock units (RSUs) on June 17, 2026.
• The grant is reported at a per-share value of $94.97, for a total grant value of $2,499,990. This is an award/compensation grant (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-06-17; Form 4 filed: 2026-06-22 (filed after the 2-business-day window — appears late).
• Shares/grant: 26,324 RSUs at $94.97 each; total reported value $2,499,990.
• Vesting: RSUs vest in three equal installments — 1/3 on each of June 17, 2027, 2028 and 2029 (per filing footnote).
• Shares owned after transaction: not specified in this Form 4 filing.
• Transaction type code: A = Award/Grant. No tax-withholding or 10b5-1 plan noted in the provided filing footnote.

Context

• This was a compensation award (RSUs). Such grants are routine for executive compensation and do not represent an open-market purchase or sale. The RSUs will convert to shares only as they vest according to the schedule above.
• The Form 4 was filed on 2026-06-22 for a 2026-06-17 grant, which appears to be late relative to the two-business-day filing requirement for insiders.